Faes Farma, S.A. (BME:FAE)

Market Cap	1.45B +31.8%
Revenue (ttm)	626.99M +22.9%
Net Income	79.63M -28.5%
EPS	0.25 -28.7%
Shares Out	311.26M
PE Ratio	18.37
Forward PE	15.30
Dividend	0.18 (3.81%)
Ex-Dividend Date	Jan 8, 2026

Volume	139,692
Average Volume	167,784
Open	4.710
Previous Close	4.695
Day's Range	4.650 - 4.780
52-Week Range	3.510 - 5.440
Beta	0.32
RSI	47.78
Earnings Date	Apr 30, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securiti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 1,894
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: FAE

Financial Performance

In 2025, Faes Farma's revenue was 626.99 million, an increase of 22.93% compared to the previous year's 510.04 million. Earnings were 79.63 million, a decrease of -28.49%.